Clinical Trial Update: Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02) [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial evaluates neoadjuvant immunotherapy combined with chemotherapy followed by endoscopic resection for esophageal squamous cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 1 | Status: RECRUITING